Literature DB >> 16818632

MYC can induce DNA breaks in vivo and in vitro independent of reactive oxygen species.

Suma Ray1, Kondala R Atkuri, Debabrita Deb-Basu, Adam S Adler, Howard Y Chang, Leonore A Herzenberg, Dean W Felsher.   

Abstract

MYC overexpression is thought to initiate tumorigenesis by inducing cellular proliferation and growth and to be restrained from causing tumorigenesis by inducing cell cycle arrest, cellular senescence, and/or apoptosis. Here we show that MYC can induce DNA breaks both in vitro and in vivo independent of increased production of reactive oxygen species (ROS). We provide an insight into the specific circumstances under which MYC generates ROS in vitro and propose a possible mechanism. We found that MYC induces DNA double-strand breaks (DSBs) independent of ROS production in murine lymphocytes in vivo as well as in normal human foreskin fibroblasts (NHFs) in vitro in normal (10%) serum, as measured by gammaH2AX staining. However, NHFs cultured in vitro in low serum (0.05%) and/or ambient oxygen saturation resulted in ROS-associated oxidative damage and DNA single-strand breaks (SSBs), as measured by Ape-1 staining. In NHFs cultured in low versus normal serum, MYC induced increased expression of CYP2C9, a gene product well known to be associated with ROS production. Specific inhibition of CYP2C9 by small interfering RNA was shown to partially inhibit MYC-induced ROS production. Hence, MYC overexpression can induce ROS and SSBs under some conditions, but generally induces widespread DSBs in vivo and in vitro independent of ROS production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818632     DOI: 10.1158/0008-5472.CAN-05-3115

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.

Authors:  Silvia Maifrede; Kayla Martin; Paulina Podszywalow-Bartnicka; Katherine Sullivan-Reed; Samantha K Langer; Reza Nejati; Yashodhara Dasgupta; Michael Hulse; Daniel Gritsyuk; Margaret Nieborowska-Skorska; Lena N Lupey-Green; Huaqing Zhao; Katarzyna Piwocka; Mariusz A Wasik; Italo Tempera; Tomasz Skorski
Journal:  Mol Cancer Res       Date:  2017-06-20       Impact factor: 5.852

Review 2.  Facilitating replication under stress: an oncogenic function of MYC?

Authors:  Steffi Herold; Barbara Herkert; Martin Eilers
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

Review 3.  Stem cell-based therapies for spinal cord injury.

Authors:  Rishi S Nandoe Tewarie; Andres Hurtado; Ronald H Bartels; Andre Grotenhuis; Martin Oudega
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

4.  The involvement of c-Myc in the DNA double-strand break repair via regulating radiation-induced phosphorylation of ATM and DNA-PKcs activity.

Authors:  Fengmei Cui; Rong Fan; Qiu Chen; Yongming He; Man Song; Zengfu Shang; Shimeng Zhang; Wei Zhu; Jianping Cao; Hua Guan; Ping-Kun Zhou
Journal:  Mol Cell Biochem       Date:  2015-06-07       Impact factor: 3.396

5.  Genomic instability in induced stem cells.

Authors:  C E Pasi; A Dereli-Öz; S Negrini; M Friedli; G Fragola; A Lombardo; G Van Houwe; L Naldini; S Casola; G Testa; D Trono; P G Pelicci; T D Halazonetis
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

6.  c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells.

Authors:  Amanda Guffei; Zelda Lichtensztejn; Amanda Gonçalves Dos Santos Silva; Sherif F Louis; Andrea Caporali; Sabine Mai
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

7.  Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Authors:  Stefano Campaner; Mirko Doni; Per Hydbring; Alessandro Verrecchia; Lucia Bianchi; Domenico Sardella; Thomas Schleker; Daniele Perna; Susanna Tronnersjö; Matilde Murga; Oscar Fernandez-Capetillo; Mariano Barbacid; Lars-Gunnar Larsson; Bruno Amati
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

8.  Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.

Authors:  Haitao Luo; Gary O Rankin; Lingzhi Liu; Matthew K Daddysman; Bing-Hua Jiang; Yi Charlie Chen
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

9.  Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells.

Authors:  Sudha Mannava; Vladimir Grachtchouk; Linda J Wheeler; Michael Im; Dazhong Zhuang; Elena G Slavina; Christopher K Mathews; Donna S Shewach; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2008-06-03       Impact factor: 4.534

10.  Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage.

Authors:  Lina Guerra; Ami Albihn; Susanna Tronnersjö; Qinzi Yan; Riccardo Guidi; Bo Stenerlöw; Torsten Sterzenbach; Christine Josenhans; James G Fox; David B Schauer; Monica Thelestam; Lars-Gunnar Larsson; Marie Henriksson; Teresa Frisan
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.